Aubrey Capital Management LTD Zoetis Inc. Transaction History

Aubrey Capital Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$157.07 - $174.35 $5.36 Million - $5.95 Million	-34,100 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$137.1 - $165.37 $246,780 - $297,666	1,800 Added 5.57%	34,100 $5.64 Million
Q2 2020 Aug 10, 2020	SELL	$111.92 - $142.53 $917,744 - $1.17 Million	-8,200 Reduced 20.25%	32,300 $4.43 Million
Q1 2020 Apr 30, 2020	SELL	$92.66 - $144.94 $185,320 - $289,880	-2,000 Reduced 4.71%	40,500 $4.77 Million
Q4 2019 Feb 13, 2020	SELL	$116.25 - $133.25 $453,375 - $519,675	-3,900 Reduced 8.41%	42,500 $5.62 Billion
Q3 2019 Nov 04, 2019	BUY	$112.57 - $128.43 $382,738 - $436,662	3,400 Added 7.91%	46,400 $5.78 Million
Q1 2019 May 14, 2019	BUY	$81.56 - $100.67 $570,920 - $704,690	7,000 Added 19.44%	43,000 $0
Q4 2017 Feb 12, 2018	BUY	$63.24 - $72.8 $2.28 Million - $2.62 Million	36,000	36,000 $0

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Aubrey Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Aubrey Capital Management LTD with notifications on news.